In Vitro ADMET Laboratories Inc., Columbia, Maryland (A.P.L., C.L.) and In Vitro ADMET Laboratories Inc., Malden, Massachusetts (M.-C.D.H., K.A.)
In Vitro ADMET Laboratories Inc., Columbia, Maryland (A.P.L., C.L.) and In Vitro ADMET Laboratories Inc., Malden, Massachusetts (M.-C.D.H., K.A.).
Drug Metab Dispos. 2018 Nov;46(11):1608-1616. doi: 10.1124/dmd.117.079657. Epub 2018 Jan 23.
We report here a novel experimental system, cryopreserved MetMax human hepatocytes (MMHHs), for in vitro drug metabolism studies. MMHHs consist of cofactor-supplemented permeabilized cryopreserved human hepatocytes. The use procedures for MMHHs are significantly simplified from that for conventional cryopreserved human hepatocytes (CCHHs): 1) storage at -80°C instead of in liquid nitrogen and 2) usage directly after thawing without centrifugation and microscopic evaluation of cell density and viability and cell density adjustment. In this study, we compared MMHHs and CCHHs in CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP2J2, monoamine oxidase A, aldehyde oxidase, flavin-containing monooxygenase, UDP-glucuronyl transferase, SULT, -acetyltransferase 1, and acetaminophen glutathione (GSH) conjugation activities based on liquid chromatography-tandem mass spectrometry quantification of substrate metabolism. MMHHs were prepared from CCHHs consisting of hepatocytes pooled from 10 individual donors. The drug metabolizing enzyme activities of both CCHHs and MMHHs were cell concentration and time dependent, with specific activities of MMHHs ranging from 27.2% (carboxylesterase 2) to 234.2% (acetaminophen GSH conjugation) of that for CCHHs. As observed in CCHHs, sequential oxidation and conjugation was observed in MMHHs for coumarin, 7-ethoxycoumarin, and acetaminophen. 7-Hydroxycoumarin conjugation results showed that metabolic pathways in MMHHs could be selected via the choice of cofactors, with glucuronidation but not sulfation observed in the presence of UDP-glucuronic acid and not 3-phosphoadenosine-5-phosphosulfate, and vice versa. Results with noncytotoxic and cytotoxic concentrations of acetaminophen showed that drug metabolism was compromised in CCHHs but not in MMHHs. Our results suggest that the MMHHs system represents a convenient and robust in vitro experimental system for the evaluation of drug metabolism.
我们在此报告一种新的实验系统,即冷冻保存的 MetMax 人肝细胞(MMHHs),用于体外药物代谢研究。MMHHs 由辅因子补充的渗透冷冻保存的人肝细胞组成。与传统的冷冻保存的人肝细胞(CCHHs)相比,MMHHs 的使用程序大大简化:1)储存在-80°C 而不是液氮中,2)直接解冻后使用,无需离心和显微镜评估细胞密度和活力以及细胞密度调整。在这项研究中,我们比较了 MMHHs 和 CCHHs 在 CYP1A2、CYP2A6、CYP2B6、CYP2C8、CYP2C9、CYP2D6、CYP2E1、CYP3A4、CYP2J2、单胺氧化酶 A、醛氧化酶、黄素单加氧酶、UDP-葡糖醛酸基转移酶、SULT、-乙酰基转移酶 1 和对乙酰氨基酚谷胱甘肽(GSH)缀合活性方面的基于液相色谱-串联质谱定量的底物代谢。MMHHs 是从由 10 个个体供体汇集的肝细胞组成的 CCHHs 中制备的。CCHHs 和 MMHHs 的药物代谢酶活性均与细胞浓度和时间有关,MMHHs 的比活性范围为 CCHHs 的 27.2%(羧酸酯酶 2)至 234.2%(对乙酰氨基酚 GSH 缀合)。与 CCHHs 中观察到的情况一样,在 MMHHs 中观察到香豆素、7-乙氧基香豆素和对乙酰氨基酚的顺序氧化和缀合。7-羟基香豆素缀合结果表明,MMHHs 中的代谢途径可以通过选择辅因子来选择,在存在 UDP-葡萄糖醛酸而不是 3-磷酸腺苷-5-磷酸硫酸酯时观察到葡糖醛酸化但不是硫酸化,反之亦然。非细胞毒性和细胞毒性浓度的对乙酰氨基酚的结果表明,药物代谢在 CCHHs 中受损,但在 MMHHs 中没有。我们的结果表明,MMHHs 系统代表了一种用于评估药物代谢的方便且强大的体外实验系统。